Spain· ES:1191353001
ATAZANAVIR KRKA 150 MG CAPSULAS DURAS EFG
A atazanavir product containing atazanavir, registered in Spain by Krka D.D. Novo Mesto. The same ATC class is registered in 17 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Atazanavir is registered in 17 of 19 countries.
Countries holding a registration under ATC J05AE08 (atazanavir), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 10 of them publish a price we can compare per daily dose
Atazanavir · ATC J05AE08
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of atazanavir costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Atazanavir · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$14.11
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- atazanavir
- Manufacturer
- Krka D.D. Novo Mesto
- Country
- Spain (ES)
- ATC code
- J05AE08
- ATC class
- Atazanavir
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
429 interactions on record for atazanavir.
Graded by severity as the source publishes them — 135 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atazanavir · interactions on record
429 records
- 135 severe
- 204 moderate
- 14 minor
- 50 info
Most severe, free to view
- CimetidineA02BA01severe
- RanitidineA02BA02severe
- FamotidineA02BA03severe
- NizatidineA02BA04severe
26 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Atazanavir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAtazanavir Accord 150 mg harde capsulesAccord Healthcare B.V.
- CzechiaATAZANAVIR VIATRISVIATRIS LIMITED, Dublin
- FinlandAtazanavir KrkaKRKA d.d. Novo mesto
- BelgiumAtazanavir Krka 150 mgKRKA d.d. Novo mesto
- FranceATAZANAVIR BIOGARAN 150 mg, géluleBIOGARAN
- PolandAtazanavir AccordAccord Healthcare Polska Sp. z o.o.
- SwedenAtazanavir Krka 150 mg Kapsel, hårdKrka d.d., Novo mesto
- United StatesAtazanavirCamber Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Cyprus · Atazanavir Remedica
- Czechia · Atazanavir Accord
- Germany · Atazanavir Accord, Atazanavir Al
- Denmark · Atazanavir Stada
- Finland · Atazanavir Stada
- France · Atazanavir Arrow, Atazanavir Biogaran
- United Kingdom (Northern Ireland) · Atazanavir Accord, Atazanavir Amarox
- Croatia · Atazanavir Accord
- Ireland · Atazanavir Rowex
- Iceland · Atazanavir Stada, Atazanavir Stada 150 Mg Hörð Hylki
- Italy · Atazanavir Sandoz
- Liechtenstein · Atazanavir Viatris, Reyataz
- Latvia · Atazanavir Sandoz
- Netherlands · Atazanavir Accord, Atazanavir Medicopharm
- Norway · Atazanavir Viatris, Reyataz
- Portugal · Atazanavir Farmoz, Atazanavir Generis
- Romania · Atazanavir Stada, Atazanavir Teva
- Sweden · Atazanavir Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd9f3bab-78e9-4c49-aaed-3bf2661d9e55 GET /v1/drugs/cd9f3bab-78e9-4c49-aaed-3bf2661d9e55?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1559167200000}",
"nregistro": "1191353001",
"substance": "atazanavir"
}See everything about atazanavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.